Office Medicine has completed the EMR Stage II certification testing process as a FULL Ambulatory EMR.
The application dated 12/30/2013 has been processed.
Results for each category and quality measures are posted below.
This Complete EHR is 2014 Edition compliant and has been certified by
an ONC-ACB in accordance with the applicable certification criteria
adopted by the Secretary of Health and Human Services. This certification
does not represent an endorsement by the U.S. Department of Health and
Human Services.
-
Vendor name: Digital Medical Solutions Inc.
-
Certification date: January 8, 2015
-
EHR Product version: 14
-
Unique certification number: or other product identification: IG-2373-14-0095
-
Clinical quality measures tested and certified: See below
-
Additional software required: NwHIN Java RI Direct 3.0, Round Cube secure email ( The additional software above is included with Office Medicine updates ) Additional types of costs that a user may be required to pay to implement or use the Complete EHR whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT’s certification: Technical and/or contractual limitations of the software This includes limitations when connecting with other entities (registries, labs, HISPs, etc.), limitations regarding use of data, limits on quantities of certain functions (messaging, transmissions, etc.), and others: None Ongoing training or support services Level 1, $65.00/hr. Level 2, $135.00/hr. Limitations that a user may encounter in the course of implementing and using the Complete EHR whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT’s certification: Platform: Windows
Ambulatory Clinical Quality Measures
Measure Version Domain NQF # ‡ CMS2 Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan v3 Population/Public Health NQF 0418 CMS22 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented v2 Population/Public Health N/A ‡ CMS50 Closing the referral loop: receipt of specialist report Care Coordination CMS52 HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis Clinical Process/Effectiveness NQF 0405 CMS56 Functional status assessment for hip replacement v2 Patient & Family Engagement N/A CMS61 Preventive Care and Screening: Cholesterol � Fasting Low Density Lipoprotein (LDL-C) Test Performed Clinical Process/Effectiveness CMS61 Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed v3 Clinical Process/Effectiveness N/A CMS62 HIV/AIDS: Medical Visit Clinical Process/Effectiveness CMS64 Preventive Care and Screening: Risk- Stratified Cholesterol � Fasting Low Density Lipoprotein (LDL-C) Clinical Process/Effectiveness CMS64 Preventive Care and Screening: Risk- Stratified Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Clinical Process/Effectiveness N/A CMS65 Hypertension: Improvement in blood pressure v3 Clinical Process/Effectiveness N/A CMS66 Functional status assessment for knee replacement v2 Patient & Family Engagement N/A ‡ CMS68 Documentation of Current Medications in the Medical Record v3 Patient Safety NQF 0419 ‡ CMS69 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up v2 Population/Public Health NQF 0421 CMS74 Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists Clinical Process/Effectiveness ‡ CMS75 Children who have dental decay or cavities Clinical Process/Effectiveness CMS77 HIV/AIDS: RNA control for Patients with HIV Clinical Process/Effectiveness CMS82 Maternal depression screening Population/Public Health NQF 1401 ‡ CMS90 Functional status assessment for complex chronic conditions Patient & Family Engagement ‡ CMS117 Childhood Immunization Status Population/Public Health NQF 0038 CMS122 Diabetes: Hemoglobin A1c Poor Control v2 Clinical Process/Effectiveness NQF 0059 CMS123 Diabetes: Foot Exam v2 Clinical Process/Effectiveness NQF 0056 CMS124 Cervical Cancer Screening Clinical Process/Effectiveness NQF 0032 CMS125 Breast Cancer Screening Clinical Process/Effectiveness ‡ CMS126 Use of Appropriate Medications for Asthma v2 Clinical Process/Effectiveness NQF 0036 CMS127 Pneumonia Vaccination Status for Older Adults v2 Clinical Process/Effectiveness NQF 0043 CMS128 Anti-depressant Medication Management v2 Clinical Process/Effectiveness NQF 0105 CMS129 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients Efficient Use of Healthcare Resources NQF 0389 CMS130 Colorectal Cancer Screening Clinical Process/Effectiveness NQF 0034 CMS131 Diabetes: Eye Exam v2 Clinical Process/Effectiveness NQF 0055 CMS132 Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures Patient Safety NQF 0564 CMS133 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery v2 Clinical Process/Effectiveness NQF 0565 CMS134 Diabetes: Urine Protein Screening Clinical Process/Effectiveness NQF 0062 CMS135 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) v2 Clinical Process/Effectiveness NQF 0081 ‡ CMS136 ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication v3 Clinical Process/Effectiveness NQF 0108 CMS137 Initiation and Engagement of Alcohol and Other Drug Dependence Treatment v2 Clinical Process/Effectiveness NQF 0004 ‡ CMS138 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention v2 Population/Public Health NQF 0028 CMS139 Screening for Future Fall Risk v2 Patient Safety NQF 0101 CMS140 Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer Clinical Process/Effectiveness NQF 0387 CMS141 Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients Clinical Process/Effectiveness NQF 0385 CMS142 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care v2 Clinical Process/Effectiveness NQF 0089 CMS143 Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation v2 Clinical Process/Effectiveness NQF 0086 CMS144 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) Clinical Process/Effectiveness NQF 0083 CMS145 Coronary Artery Disease (CAD): Beta-Blocker Therapy- Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) v2 Clinical Process/Effectiveness NQF 0070 ‡ CMS146 Appropriate Testing for Children with Pharyngitis v2 Efficient Use of Healthcare Resources NQF 0002 CMS147 Preventative Care and Screening: Influenza Immunization v2 Population/Public Health NQF 0041 CMS148 Hemoglobin A1c Test for Pediatric Patients v2 Clinical Process/Effectiveness NQF 0060 CMS149 Dementia: Cognitive Assessment Clinical Process/Effectiveness ‡ CMS153 Chlamydia Screening for Women Population/Public Health NQF 0033 ‡ CMS154 Appropriate Treatment for Children with Upper Respiratory Infection (URI) v2 Efficient Use of Healthcare Resources NQF 0069 ‡ CMS155 Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents v2 Population/Public Health NQF 0024 ‡ CMS156 Use of High-Risk Medications in the Elderly Patient Safety NQF 0022 CMS157 Oncology: Medical and Radiation � Pain Intensity Quantified Patient & Family Engagement NQF 0384 CMS157 Oncology: Medical and Radiation – Pain Intensity Quantified Patient & Family Engagement NQF 0384 CMS158 Pregnant women that had HBsAg testing Clinical Process/Effectiveness CMS159 Depression Remission at Twelve Months v2 Clinical Process/Effectiveness NQF 0710 CMS160 Depression Utilization of the PHQ-9 Tool Clinical Process/Effectiveness NQF 0712 CMS161 Major Depressive Disorder (MDD): Suicide Risk Assessment v2 Clinical Process/Effectiveness NQF 0104 CMS163 Diabetes: Low Density Lipoprotein (LDL) Management v2 Clinical Process/Effectiveness NQF 0064 CMS164 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic v2 Clinical Process/Effectiveness NQF 0068 ‡ CMS165 Controlling High Blood Pressure v2 Clinical Process/Effectiveness NQF 0018 ‡ CMS166 Use of Imaging Studies for Low Back Pain v3 Efficient Use of Healthcare Resources NQF 0052 CMS167 Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy v2 Clinical Process/Effectiveness NQF 0088 CMS169 Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use Clinical Process/Effectiveness NQF 0110 CMS177 Child and Adolescent Major Depressive Disorder: Suicide Risk Assessment v2 Patient Safety NQF 1365 CMS179 ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range. v2 Patient Safety N/A CMS182 Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control v3 Clinical Process/Effectiveness NQF 0075
|
Criterion # | Certification Criterion Name | Document Type | Last Revised |
---|---|---|---|
§170.314(a)(1) | Computerized provider order entry | Test Procedure [PDF – 465 KB] |
*12/19/14 |
Test Data [PDF – 129 KB] |
04/26/13 | ||
§170.314(a)(2) | Drug-drug, drug-allergy interactions checks | Test Procedure [PDF – 393 KB] |
12/14/12 |
§170.314(a)(3) | Demographics | Test Procedure [PDF – 395 KB] |
12/14/12 |
Test Data [PDF – 77 KB] |
02/26/13 | ||
§170.314(a)(4) | Vital signs, body mass index, and growth Charts | Test Procedure [PDF – 135 KB] |
06/28/13 |
Test Data [PDF – 73 KB] |
01/16/13 | ||
§170.314(a)(5) | Problem list | Test Procedure [PDF – 134 KB] |
06/28/13 |
Test Data [PDF – 95 KB] |
01/16/13 | ||
§170.314(a)(6) | Medication list | Test Procedure [PDF – 116 KB] |
06/28/13 |
Test Data [PDF – 84 KB] |
02/26/13 | ||
§170.314(a)(7) | Medication allergy list | Test Procedure [PDF – 136 KB] |
06/28/13 |
Test Data [PDF – 96 KB] |
01/16/13 | ||
§170.314(a)(8) | Clinical decision support | Test Procedure [PDF – 519 KB] |
*12/24/14 |
§170.314(a)(9) | Electronic notes | Test Procedure [PDF – 380 KB] |
05/08/13 |
Test Data [PDF – 62 KB] |
01/16/13 | ||
§170.314(a)(10) | Drug formulary checks | Test Procedure [PDF – 110 KB] |
12/14/12 |
Test Data [PDF – 69 KB] |
02/26/13 | ||
§170.314(a)(11) | Smoking status | Test Procedure [PDF – 111 KB] |
06/28/13 |
§170.314(a)(12) | Image results | Test Procedure [PDF – 337 KB] |
02/26/13 |
§170.314(a)(13) | Family health history | Test Procedure [PDF – 467 KB] |
12/14/12 |
§170.314(a)(14) | Patient list creation | Test Procedure [PDF – 490 KB] |
12/14/12 |
§170.314(a)(15) | Patient-specific education resources | Test Procedure [PDF – 94 KB] |
06/28/13 |
§170.314(a)(16) | Inpatient setting only -electronic medication administration record | Test Procedure [PDF – 467 KB] |
*12/24/14 |
Test Data [PDF – 386 KB] |
12/14/12 | ||
§170.314(a)(17) | Advance directives | Test Procedure [PDF – 85 KB] |
12/14/12 |
§170.314(a)(18) | Optional – computerized provider order entry – medications | Test Procedure [PDF – 576 KB] |
*12/24/14 |
§170.314(a)(19) | Optional – computerized provider order entry – laboratory | Test Procedure [PDF – 582 KB] |
*12/24/14 |
§170.314(a)(20) | Optional – computerized provider order entry – diagnostic imaging | Test Procedure [PDF – 582 KB] |
*12/24/14 |
§170.314(b)(1) | * Transitions of care – receive, display and incorporate transition of care/referral summaries | Test Procedure [PDF – 452 KB] |
03/21/14 |
Test Data [PDF – 173 KB] |
03/21/14 | ||
§170.314(b)(2) | * Transitions of care – create and transmit transition of care/referral summaries | Test Procedure [PDF – 650 KB] |
03/01/13 |
Test Data [PDF – 183 KB] |
03/21/14 | ||
§170.314(b)(3) | Electronic prescribing | Test Procedure [PDF – 420 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
06/10/13 |
§170.314(b)(4) | Clinical information reconciliation | Test Procedure [PDF – 469 KB] |
01/16/13 |
Test Data [PDF – 99 KB] |
02/26/13 | ||
§170.314(b)(5)(A) | Incorporate laboratory tests and values/results | Test Procedure [PDF – 820 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
02/26/13 |
Guidelines for Configuring and Priming the EHR [PDF – 155 KB] |
03/20/13 | ||
§170.314(b)(5)(B) | Incorporate laboratory tests and values/results | Test Procedure [PDF – 685 KB] |
12/14/12 |
Test Data [PDF – 627 KB] |
12/14/12 | ||
§170.314(b)(6) | Inpatient setting only – transmission of electronic laboratory tests and values/results to ambulatory providers | Test Procedure [PDF – 828 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
01/16/13 |
Guidelines for Pre-loading Test Data [PDF – 97 KB] |
03/20/13 | ||
§170.314(b)(7) | Data portability | Test Procedure [PDF – 551 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
05/08/13 |
Test Data [PDF – 354 KB] |
06/19/14 | ||
§170.314(b)(9) | Optional – clinical information reconciliation and incorporation (CIRI) | Test Procedure [PDF – 448 KB] |
*12/24/14 |
§170.314(c)(1) | Clinical quality measures – capture and export | Test Procedure [PDF – 2.2 MB] |
*12/24/14 |
§170.314(c)(2) | Clinical quality measures – import and calculate | ||
§170.314(c)(3) | Clinical quality measures – electronic submission | ||
§170.314(d)(1) | Authentication, access, control, and authorization | Test Procedure [PDF – 357 KB] |
12/14/12 |
§170.314(d)(2) | Auditable events and tamper-resistance | Test Procedure [PDF – 491 KB] |
*12/24/14 |
§170.314(d)(3) | Audit report(s) | Test Procedure [PDF – 395 KB] |
05/08/13 |
§170.314(d)(4) | Amendments | Test Procedure [PDF – 188 KB] |
03/21/14 |
§170.314(d)(5) | Automatic log-off | Test Procedure [PDF – 84 KB] |
12/14/12 |
§170.314(d)(6) | Emergency access | Test Procedure [PDF – 88 KB] |
12/14/12 |
§170.314(d)(7) | End-user device encryption | Test Procedures [PDF – 480 KB] |
12/14/12 |
§170.314(d)(8) | Integrity | Test Procedure [PDF – 97 KB] |
12/14/12 |
§170.314(d)(9) | Optional – accounting of disclosures | Test Procedure [PDF – 113 KB] |
12/14/12 |
§170.314(e)(1) | * View, download, and transmit to 3rd party | Test Procedure [PDF – 762 KB] |
*12/24/14 |
Test Data [PDF – 169 KB] |
03/21/14 | ||
§170.314(e)(2) | Ambulatory setting only -clinical summary | Test Procedure [PDF – 766 KB] |
12/14/12 |
Test Data [PDF – 147 KB] |
03/21/14 | ||
§170.314(e)(3) | Ambulatory setting only – secure messaging | Test Procedure [PDF – 528 KB] |
01/16/13 |
§170.314(f)(1) | Immunization information | Test Procedure [PDF – 381 KB] |
12/14/12 |
Test Data [PDF – 384 KB] |
12/14/12 | ||
§170.314(f)(2) | Transmission to immunization registries | Test Procedures [PDF – 706 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
01/16/13 |
Guidelines for Pre-loading Test Data [PDF – 97 KB] | 03/20/13 | ||
§170.314(f)(3) | Transmission to public health agencies – syndromic surveillance | Test Procedure [PDF – 767 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
01/16/13 |
Guidelines for Pre-loading Test Data [PDF – 181 KB] | 03/20/13 | ||
§170.314(f)(4) | Inpatient setting only – transmission of reportable laboratory tests and values/results | Test Procedure [PDF – 1.05 MB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
01/16/13 |
Guidelines for Pre-loading Test Data [PDF – 97 KB] | 03/20/13 | ||
§170.314(f)(5) | Optional – ambulatory setting only – cancer case information | Test Procedure [PDF – 353 KB] |
12/14/12 |
Test Data [PDF – 425 KB] |
12/14/12 | ||
§170.314(f)(6) | Optional – ambulatory setting only – transmission to cancer registries | Test Procedure [PDF – 699 KB] Test Data and Test Tools are available via a hyperlink in the Test Procedure, as applicable. |
07/23/14 |
Guidelines for Pre-loading Test Data [PDF – 85 KB] | 03/20/13 | ||
§170.314(f)(7) | Optional – ambulatory setting only – transmission to public health agencies – syndromic surveillance | Test Procedure [PDF – 537 KB] |
*12/24/14 |
§170.314(g)(1) | Automated numerator recording | Test Procedure [PDF – 1.8 MB] |
*12/19/14 |
Test Data [XLSX – 259 KB] |
06/19/14 | ||
§170.314(g)(2) | Automated measure calculation | Test Procedure [PDF – 1.8 MB] |
*12/19/14 |
Test Data [XLSX – 200 KB] |
06/19/14 | ||
§170.314(g)(3) | Safety-enhanced design | Test Procedure [PDF – 431 KB] |
*12/19/14 |
§170.314(g)(4) | Quality management system | Test Procedure [PDF – 90 KB] |
12/14/12 |
§170.314(h)(1) | Optional – Transmit – Applicability Statement for Secure Health | Test Procedure [PDF – 1 MB] |
*12/24/14 |
§170.314(h)(2) | Optional – Transmit – Applicability Statement for Secure Health Transport and XDR/XDM for Direct Messaging | Test Procedure [PDF – 580 KB] |
*12/24/14 |
§170.314(h)(3) | Optional – Transmit – SOAP Transport and Security Specification and XDR/XDM for Direct Messaging | Test Procedure [PDF – 727 KB] |
*12/24/14 |